Anti-Gal9 antibody (Fibrogen)

N/A

Report date: 2024/06/20 17:08:15

Base Information

Drug NameAnti-Gal9 antibody (Fibrogen)
Drug Alias NameFG-3165HFB-200901HFB-200902HFB2009HFB2009 series +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Galactoside-binding lectin Galectin 9
TargetsGalactoside-binding lectin Galectin 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesHiFiBiO Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesFibrogen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A